Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data

Psoriasis is a systemic disease that is linked to cardiometabolic complications. Paraoxonase 1 (PON1) exerts anti-atherogenic properties. Pentraxin 3 (PTX3) is related to heart failure and atherosclerosis. We aimed to evaluate the protein levels in psoriatic patients and explore possible relations w...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Anna Baran, Anna Stepaniuk, Paulina Kiluk, Tomasz W. Kaminski, Magdalena Maciaszek, Iwona Flisiak
Materialtyp: Artikel
Språk:English
Publicerad: MDPI AG 2022-06-01
Serie:Metabolites
Ämnen:
psoriasis
pentraxin 3
paraoxonase 1
comorbidities
cardiovascular biomarker
systemic therapy
Länkar:https://www.mdpi.com/2218-1989/12/7/580

Internet

https://www.mdpi.com/2218-1989/12/7/580

Liknande verk